Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Fierce 50
Special Report
Awards Gala
Awards
CRO Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Jakafi
Fierce Pharma
New Incyte CEO takes 'fresh look' at business, outlines BD plan
Incyte will look for “derisked pre-revenue or revenue-stage opportunities,” new CEO Bill Meury said.
Angus Liu
Aug 4, 2025 11:16am
Ironwood spies new frontier for $1B drug in exploratory trial
Mar 28, 2024 9:00am
Novartis will pay €2.7B to pick up cancer specialist MorphoSys
Feb 5, 2024 7:06pm
Incyte scraps six R&D programs
May 2, 2023 12:48pm
Incyte's LIMBER lumbers to early end as cancer data fall short
Mar 6, 2023 5:20am
ASH: GSK explores new avenues for JAK drug from $1.9B Sierra buy
Dec 11, 2022 5:30pm
